Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiology. I. Heart failure]

W Kübler1

  • 1Abteilung Innere Medizin III, Klinikum der Universität Heidelberg.

Arzneimittel-Forschung
|February 14, 1998
PubMed
Summary

Heart failure treatment has evolved from increasing contractility to reducing afterload. Modern strategies prioritize life extension proven by randomized trials, unlike older methods focusing on symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pure beta-particle-emitting stents inhibit neointima formation in rabbits.

Circulation·1996
Same author

Serum troponin T: diagnostic marker for acute myocarditis.

Clinical chemistry·1996
Same author

-Anticoagulation after intracoronary stent implantation-.

Herz·1996
Same author

Transesophageal echo phase imaging for localizing accessory pathways during adenosine-induced preexcitation in patients with the Wolff-Parkinson-White syndrome.

The American journal of cardiology·1996
Same author

Development and characterization of a rapid assay for bedside determinations of cardiac troponin T.

Circulation·1995
Same author

Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease.

The American journal of cardiology·1995

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Context:

  • Heart failure management has shifted significantly over the past 30 years.
  • Early treatments focused on increasing myocardial contractility.
  • Current approaches emphasize afterload reduction and neurohormonal balance.

Purpose:

  • To compare historical and contemporary medical treatments for heart failure.
  • To highlight the evolution of pathophysiological understanding and therapeutic goals.
  • To emphasize the necessity of randomized controlled trials for evaluating new heart failure therapies.

Summary:

  • Treatment has evolved from general methods, diuretics, and digitalis to include afterload reduction (hydralazine/isosorbide dinitrate) and ACE inhibitors, demonstrating improved survival.
  • Diuretics show no prognostic improvement, while digitalis offers symptomatic relief but not extended life.
  • Management of ventricular tachyarrhythmias is complex; Class I antiarrhythmics are generally avoided, with betablockers or Class III agents considered cautiously. Implantable cardioverter-defibrillators are preferred for symptomatic patients.

Impact:

  • This comparison underscores the paradigm shift in heart failure treatment, moving towards evidence-based strategies focused on survival.
  • The findings emphasize the critical role of rigorous clinical trials in validating therapeutic advancements.
  • The evolution in treatment reflects a deeper understanding of heart failure pathophysiology and its long-term management.

Related Experiment Videos